Real-world experience with management of spinal ganglioneuroma: long-term follow-up observations of 31 cases

• Published in: European spine journal 2021-10, Vol.30 (10), p.2896-2905
• Main Authors: Haitao, Sun, Yao, Wang, Xin, Jiang, Xiaopan, Cai, Ting, Wang, Yan, Lou, Chenglong, Zhao, Zhipeng, Wu, Jianru, Xiao
• Format: Article
• Language: English
• Subjects: Dorsal root ganglia; Genetic disorders; Medicine; Medicine & Public Health; Neuroblastoma; Neurological complications; Neurological disorders; Neurosurgery; Original Article; Patients; Surgical Orthopedics; Tumors
• ISSN: 0940-6719; 1432-0932
• DOI: 10.1007/s00586-021-06896-z

Introduction Spinal ganglioneuroma (GN) is the most benign neoplasm of neuroblastic origin. There is little knowledge about spinal GN because of sporadic cases reported. The objective of this study is to describe the clinical manifestations and long-term follow-up outcomes of spinal GN after consecutive treatment. Methods The clinical and follow-up data of 31 patients with spinal GN receiving consecutive treatment in our institute are retrospectively analyzed. Results The mean age of the 31 patients was 40.39 ± 14.8 years. They were diagnosed with spinal GN and received surgical treatment in our institution between February 2012 and August 2019. Of them, 22 (71%) patients presented preoperative neurological symptoms. The mean duration from symptom onset to surgery was 19.76 ± 49.59 months. Eighteen patients received complete surgical resection and 13 patients received subtotal excision. In addition, radicotomy was performed simultaneously after sophisticated consideration in 19 patients. The follow-up period averaged 64.13 ± 22.67 months. The preoperative neurological dysfunction was improved significantly during the follow-up period in all cases. No local recurrence or malignant transformation has occurred so far. Conclusion Spinal GN is a rare but benign neoplasm, and the origin of spinal GN remains controversial. With our experience, we propose that the origin of spinal GN from dorsal root ganglion should be equally considered as its counterpart of sympathetic ganglion. Complete resection is the preferred surgical strategy to avoid malignant events and recurrence. And the close postoperative follow-up observations are warranted.